News | March 02, 2026
Emcure partners with Roche to boost nephrology and transplant care in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
AINU is set to accelerate its expansion footprint, enhance operational capabilities
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
